PharmaShots Weekly Snapshot (Nov 23 - 27, 2020)
Merck Collaborates with Siemens for the Digitalization of Production
Published: Nov 26, 2020 | Tags: Agreement, Collaborative, Digitalization, Merck, Siemens, Sign
CoSara Receives CDSCO's Approval for its Saragene COVID-19 2-Gene Multiplex Test
Published: Nov 26, 2020 | Tags: approval, CDSCO, Co-Diagnostics JV CoSara, COVID-19 2-gene multiplex RT-PCR, India, Manufacture, receives, Saragene, Sell, Test
PostEra Collaborates with NeuroLucent to Identify Therapies for Alzheimer's Disease
Published: Nov 25, 2020 | Tags: Agreement, Alzheimer Disease, Collaborative, Develop, NeuroLucent, Novel, PostEra, Sign, Treatment
BASE10 Collaborates with DNA Link to Support Authorization of COVID-19 IgG Antibody Test at the Point of Care
Published: Nov 26, 2020 | Tags: BASE10, Collaborates, DNA, Link, Support, Authorization, COVID-19, IgG Antibody, Test, Point, Care
Egle Identifies First Novel Regulatory T-cell Targets Under its Collaboration with Takeda
Published: Nov 26, 2020 | Tags: Agreement, Alliance, Egle, First, Identifies, Novel, Regulatory, Research, T-cell, Takeda, Targets, therapeutics
Merck KGaA Reports EMA's Validation of MAA for Tepotinib to Treat Advanced NSCLC with METex14 Skipping Alterations
Published: Nov 26, 2020 | Tags: Advanced NSCLCs, EMA's Validation, MAA, Merck, reports, Tepotinib, Treat
Y-mAbs' Danyelza (naxitamab-gqgk) Receives the US FDA's Approval for Neuroblastoma
Published: Nov 25, 2020 | Tags: (naxitamab-gqgk), approval, Danyelza, Neuroblastoma, receives, US FDA's, Y-mAbs Therapeutics
CorticoMetrics's THINQ Receives the US FDA's 510(k) Clearance for MRI Brain Volumetric Reporting
Published: Nov 24, 2020 | Tags: 510(k), Brain, Clearance, CorticoMetrics, MRI, receives, Reporting, THINQ, Us FDA, Volumetric
BioNTech and Fosun Pharma Initiate P-ll Study of BNT162b2 Against COVID-19 in China
Published: Nov 25, 2020 | Tags: BioNTech, BNT162b2, China, Clinical Trial, Covid-19 Vaccine, Fosun Pharma, Lead mRNA, P-ll, Resumes
Urovant's Vibegron Fails to Meet its Primary Endpoint in P-IIa Study for IBS Pain
Published: Nov 24, 2020 | Tags: Irritable Bowel Syndrome, P-IIa, reports, results, Sciences, study, Treatment, Urovant, Vibegron
Bio-Thera Reports MAA Submission to EMA for BAT1706 a Proposed Biosimilar to Avastin
Published: Nov 25, 2020 | Tags: Avastin, BAT1706 Proposed Biosimilar, Bio-Thera Solutions, Cancer, EMA, Marketing Authorization Application, Submits
Janssen's Tremfya (guselkumab) Receives EC's Approval as a First in Class Treatment for Active Psoriatic Arthritis
Published: Nov 25, 2020 | Tags: Active Psoriatic Arthritis (PsA), EC's Approval, First in Class, guselkumab, Janssen's, receives, Treatment, Tremfya
Bausch Health Initiates Second P-III Study for NOV03 (perfluorohexyloctane) to Treat DED Associated With MGD
Published: Nov 24, 2020 | Tags: Associated, Bausch Health, Disease, Dry Eye, Initiates, Investigational, MGD, NOV03, P-III, Second, study, Treatment
Evotec Collaborates with Rappta Therapeutics to Focus on Oncology Target
Published: Nov 24, 2020 | Tags: Agreement, Development, Discovery, Evotec, Focused, Oncology, Rappta, Signs, Target, therapeutics
Russia's Sputnik V Demonstrates 91.4% Efficacy Against COVID-19
Published: Nov 24, 2020 | Tags: COVID-19, Gamaleya Center, P-lll Study, RDIF, reports, results, Second Interim Analysis, Sputnik V
Alvotech and Alvotech & CCHT Sign an Exclusive Commercialization Agreement with Yangtze River for Eight Biosimilars in China
Published: Nov 24, 2020 | Tags: Alvotech, CCHT, China, Eight Biosimilar Medicines, Exclusive Commercialization Agreement, Sign, Yangtze River
Alnylam's Oxlumo (lumasiran) Receives the US FDA's Approval for Treatment of Primary Hyperoxaluria Type 1 in Pediatric and Adult Patients
Published: Nov 24, 2020 | Tags: Adult, Alnylam, approval, Hyperoxaluria, Lumasiran, OXLUMO, patients, Pediatric, Primary, receives, Treatment, Type 1, Us FDA
BMS' Opdivo (nivolumab) Receives EC's Approval as 2L Treatment for Unresectable Advanced and Metastatic Esophageal Squamous Cell Carcinoma
Published: Nov 24, 2020 | Tags: 2L Treatment, Bristol Myers Squibb, EC's Approval, Metastatic Esophageal Squamous Cell Carcinoma (ESCC), Nivolumab, Opdivo, receives, Unresectable Advanced
Selvita to Acquire Fidelta from Galapagos for ~$37M
Published: Nov 23, 2020 | Tags: $37.08M, Acquire, Fidelta, Galapagos, Selvita
Targovax Reports Results of ONCOS-102 in P-l/ll Study as 1L and 2L Treatment for Malignant Pleural Mesothelioma
Published: Nov 24, 2020 | Tags: (SoC), 1L and 2L Treatment, Malignant Pleural Mesothelioma (MPM), ONCOS-102, P-l/ll Study, reports, results, SITC Annual Meeting, Standard of Care, Targovax
Roche's Xofluza (baloxavir marboxil) Receives the US FDA's Approval for Post-Exposure Prevention of Influenza
Published: Nov 24, 2020 | Tags: approval, baloxavir marboxil, Contact, Following, Infected, Influenza, Person, Prevention, receives, Roche, Us FDA, Xofluza
Baxter's Homechoice Claria APD System Receives the US FDA's 510 (k) Clearance for Kidney Failure
Published: Nov 23, 2020 | Tags: Baxter's, Claria Automated Peritoneal Dialysis (APD) System, Clearance, Homechoice, Kidney Failure, receives, US, US FDA's 510 (k)
Schrödinger Signs a $2.7B Agreement with BMS to Develop and Commercialize Therapies in Multiple Disease Areas
Published: Nov 23, 2020 | Tags: Agreement, Areas, BMS, Commercialize, Develop, Discover, Disease, Multiple, Schrödinger, Signs, therapeutics
Merck to Acquire OncoImmune for $425M
Published: Nov 23, 2020 | Tags: Acquire, CD24Fc program, Merck, OncoImmune
AstraZeneca's AZD1222 Meets its Primary Endpoint in Preventing COVID-19
Published: Nov 23, 2020 | Tags: AstraZeneca, AZD1222, COV002, COV003, COVID-19, P-II/III, P-III, Positive, Preventing, reports, results, Trial, vaccine
Eli Lilly Signs an Exclusive Agreement with Precision BioSciences on Genome Editing Research
Published: Nov 20, 2020 | Tags: Develop of Potential, Genetic Disorders, License Agreement, Lilly, Precision, Research, Research Collaboration, Signs, Vivo Therapies
Eiger's Zokinvy (lonafarnib) Receives the US FDA's Approval for Treatment of Progeria and Processing-Deficient PL
Published: Nov 20, 2020 | Tags: approval, Deficient, Eiger, lonafarnib, PL, Processing, Progeria, receives, Treatment, Us FDA, Zokinvy
Innovent Reports Results of Tyvyt + Byvasda (biosimilar, bevacizumab) in P-lll ORIENT-32 Study as 1L Treatment for HCC
Published: Nov 22, 2020 | Tags: 1L treatment, Advanced Hepatocellular Carcinoma (HCC), Byvasda, ESMO ASIA Virtual Congress 2020, Innovent, ORIENT-32 Study, P-lll, reports, results, Tyvyt
Lilly's Bamlanivimab (LY-CoV555) Receives Health Canada's Interim Authorization as a Treatment for COVID-19
Published: Nov 20, 2020 | Tags: Authorization, Bamlanivimab, canada, COVID-19, health, Interim, Lilly, LY-CoV555, receives, Treatment
Regeneron's Casirivimab and Imdevimab Receive the US FDA's EUA as the First Combination Therapy for COVID-19
Published: Nov 21, 2020 | Tags: Casirivimab, COVID-19, EUA, Imdevimab, patients, receives, Regeneron, US FDA's
Related Post: PharmaShots Weekly Snapshot (Nov 16-20, 2020)
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com